IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 203 filers reported holding IMPAX LABORATORIES INC in Q2 2016. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2018 | $1,499,000 | +26.2% | 77,080 | +8.0% | 0.01% | +14.3% |
Q4 2017 | $1,188,000 | +485.2% | 71,352 | +613.5% | 0.01% | +600.0% |
Q3 2017 | $203,000 | -58.9% | 10,000 | -52.1% | 0.00% | -66.7% |
Q3 2016 | $494,000 | -19.8% | 20,883 | -2.4% | 0.00% | -25.0% |
Q2 2016 | $616,000 | -7.4% | 21,403 | +2.9% | 0.00% | 0.0% |
Q1 2016 | $665,000 | -25.2% | 20,793 | 0.0% | 0.00% | -20.0% |
Q4 2015 | $889,000 | +152.6% | 20,793 | +107.9% | 0.01% | +150.0% |
Q3 2015 | $352,000 | -23.3% | 10,000 | 0.0% | 0.00% | -33.3% |
Q2 2015 | $459,000 | -1.9% | 10,000 | 0.0% | 0.00% | 0.0% |
Q1 2015 | $468,000 | +48.1% | 10,000 | 0.0% | 0.00% | +50.0% |
Q4 2014 | $316,000 | +1.3% | 10,000 | -24.1% | 0.00% | 0.0% |
Q3 2014 | $312,000 | -22.2% | 13,169 | -1.7% | 0.00% | -33.3% |
Q2 2014 | $401,000 | -20.8% | 13,402 | -30.2% | 0.00% | +50.0% |
Q1 2014 | $506,000 | -72.2% | 19,208 | -73.5% | 0.00% | -71.4% |
Q4 2013 | $1,822,000 | +21.8% | 72,528 | -0.9% | 0.01% | +16.7% |
Q3 2013 | $1,496,000 | +0.7% | 73,206 | -1.8% | 0.01% | -14.3% |
Q2 2013 | $1,485,000 | – | 74,552 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |